Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoniazid Prophylaxis in Kidney Transplant Recipients
NCT06512831Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of isoniazid in Tuberculosis (TB) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: The incidence of post-transplant active TB at 5 years. Started Jun 2023; status: completed.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT06512831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06512831.